Atlas Trials

The Rilpivirine Cerebrospinal-fluid (CSF) Study

Clinical trial NCT01562886 · COMPLETED

Trial details

NCT number
NCT01562886
Sponsor
Imperial College London
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
HIV
Start date
2012-03-01
Primary completion
2012-11-01
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.